Leerink Swann Downgrades Dendreon (DNDN) to Market Perform; Modest Growth and Building Competition Becomes Concerning
Tweet Send to a FriendGet Alerts DNDN Hot Sheet
Price: $3.89 -0.51%
Rating Summary:
5 Buy, 15 Hold, 12 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
5 Buy, 15 Hold, 12 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade DNDN Now!
Leerink Swann downgraded Dendreon (NASDAQ: DNDN) from Outperform to Market Perform with a price target of $13.00.
Analyst, Howard Liang, said, "Yesterday after the market close, DNDN reported 1Q:12 Provenge sales of $82M (+$5M q/q; or +6.5%), ahead of our and consensus estimates of $79.9M and $81.2M, respectively. However, management indicated that there was a similar end-of-quarter surge in 1Q as in 4Q, and April is down from March. The company guided to low-single-digit sequential growth for 2Q, which would imply a q/q increment of less than $4M. Given the current trajectory of two consecutive quarters of sequential growth that appears less than $5M, we find upside from our current valuation of $13 difficult to justify."
Leerink lowers FY12 loss from (1.99) to (2.45) and FY13 from (1.05) to (1.57)
For an analyst ratings summary and ratings history on Dendreon click here. For more ratings news on Dendreon click here.
Shares of Dendreon closed at $11.69 yesterday, with a 52 week range of $6.46-$42.87.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Howard Liang, said, "Yesterday after the market close, DNDN reported 1Q:12 Provenge sales of $82M (+$5M q/q; or +6.5%), ahead of our and consensus estimates of $79.9M and $81.2M, respectively. However, management indicated that there was a similar end-of-quarter surge in 1Q as in 4Q, and April is down from March. The company guided to low-single-digit sequential growth for 2Q, which would imply a q/q increment of less than $4M. Given the current trajectory of two consecutive quarters of sequential growth that appears less than $5M, we find upside from our current valuation of $13 difficult to justify."
Leerink lowers FY12 loss from (1.99) to (2.45) and FY13 from (1.05) to (1.57)
For an analyst ratings summary and ratings history on Dendreon click here. For more ratings news on Dendreon click here.
Shares of Dendreon closed at $11.69 yesterday, with a 52 week range of $6.46-$42.87.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell
- Hewlett-Packard (HPQ) Q2 Performance Wins Praise on Wall Street; Jefferies Raises to Hold
- Needham & Company Boosts Numbers on Infoblox (BLOX) on Strong Q3
Create E-mail Alert Related Categories
Analyst EPS Change, Analyst EPS View, Downgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
